{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:26:00Z","timestamp":1791296760107,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T00:00:00Z","timestamp":1373328000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s15010-013-0500-5","type":"journal-article","created":{"date-parts":[[2013,7,8]],"date-time":"2013-07-08T10:01:25Z","timestamp":1373277685000},"page":"1177-1182","source":"Crossref","is-referenced-by-count":22,"title":["Cutaneous leishmaniasis in Switzerland: first experience with species-specific treatment"],"prefix":"10.1007","volume":"41","author":[{"given":"V.","family":"Mosimann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Neumayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,9]]},"reference":[{"key":"500_CR1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/jac\/dkh058","volume":"53","author":"J Blum","year":"2004","unstructured":"Blum J, Desjeux P, Schwartz E, Beck B, Hatz C. Treatment of cutaneous leishmaniasis among travellers. J Antimicrob Chemother. 2004;53:158\u201366.","journal-title":"J Antimicrob Chemother"},{"key":"500_CR2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1708-8305.2008.00286.x","volume":"16","author":"JA Blum","year":"2009","unstructured":"Blum JA, Hatz CF. Treatment of cutaneous leishmaniasis in travelers 2009. J Travel Med. 2009;16:123\u201331.","journal-title":"J Travel Med"},{"key":"500_CR3","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1055\/s-2008-1058818","volume":"119","author":"J Blum","year":"1994","unstructured":"Blum J, Hatz C, Junghanss T. The therapy of cutaneous and mucocutaneous leishmaniasis. Dtsch Med Wochenschr. 1994;119:1169\u201372.","journal-title":"Dtsch Med Wochenschr"},{"key":"500_CR4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S1473-3099(06)70492-3","volume":"6","author":"E Schwartz","year":"2006","unstructured":"Schwartz E, Hatz C, Blum J. New world cutaneous leishmaniasis in travellers. Lancet Infect Dis. 2006;6:342\u20139.","journal-title":"Lancet Infect Dis"},{"key":"500_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1610-0379.2011.07820.x","volume":"9","author":"G Boecken","year":"2011","unstructured":"Boecken G, Sunderkotter C, Bogdan C, et al. Diagnosis and therapy of cutaneous and mucocutaneous leishmaniasis in Germany. J Dtsch Dermatol Ges. 2011;9:1\u201351.","journal-title":"J Dtsch Dermatol Ges"},{"key":"500_CR6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaad.2009.06.088","volume":"63","author":"P Mitropoulos","year":"2010","unstructured":"Mitropoulos P, Konidas P, Durkin-Konidas M. New World cutaneous leishmaniasis: updated review of current and future diagnosis and treatment. J Am Acad Dermatol. 2010;63:309\u201322.","journal-title":"J Am Acad Dermatol"},{"key":"500_CR7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1586\/eri.10.19","volume":"8","author":"H Goto","year":"2010","unstructured":"Goto H, Lindoso JA. Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis. Expert Rev Anti Infect Ther. 2010;8:419\u201333.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"500_CR8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.lpm.2010.09.023","volume":"40","author":"PA Buffet","year":"2011","unstructured":"Buffet PA, Rosenthal E, Gangneux JP, et al. Therapy of leishmaniasis in France: consensus on proposed guidelines. Presse Med. 2011;40:173\u201384.","journal-title":"Presse Med"},{"key":"500_CR9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0732-8893(03)00040-3","volume":"46","author":"J Marfurt","year":"2003","unstructured":"Marfurt J, Niederwieser I, Makia D, Beck H-P, Felger I. Diagnostic genotyping of Old and New World Leishmania species by PCR-RFLP. Diagn Microbiol Infect Dis. 2003;46:115\u201324.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"500_CR10","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1128\/JCM.41.7.3147-3153.2003","volume":"41","author":"J Marfurt","year":"2003","unstructured":"Marfurt J, Nasereddin A, Niederwieser I, Jaffe CL, Beck HP, Felger I. Identification and differentiation of Leishmania species in clinical samples by PCR amplification of the miniexon sequence and subsequent restriction fragment length polymorphism analysis. J Clin Microbiol. 2003;41:3147\u201353.","journal-title":"J Clin Microbiol"},{"key":"500_CR11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1708-8305.2011.00572.x","volume":"19","author":"ALC Neumayr","year":"2012","unstructured":"Neumayr ALC, Walter C, Stoeckle M, Braendle N, Glatz K, Blum JA. Successful treatment of imported mucosal Leishmania infantum leishmaniasis with miltefosine after severe hypokalemia under meglumine antimoniate treatment. J Travel Med. 2012;19:124\u20136.","journal-title":"J Travel Med"},{"key":"500_CR12","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1365-3156.2009.02336.x","volume":"14","author":"F Pratlong","year":"2009","unstructured":"Pratlong F, Dereure J, Ravel C, et al. Geographical distribution and epidemiological features of Old World cutaneous leishmaniasis foci, based on the isoenzyme analysis of 1048 strains. Trop Med Int Health. 2009;14:1071\u201385.","journal-title":"Trop Med Int Health"},{"key":"500_CR13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.inhe.2012.06.004","volume":"4","author":"J Blum","year":"2012","unstructured":"Blum J, Lockwood DNJ, Visser L, et al. Local or systemic treatment for new world cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis. Int Health. 2012;4:153\u201363.","journal-title":"Int Health"},{"key":"500_CR14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1468-3083.2004.01133.x","volume":"19","author":"M Nassiri-Kashani","year":"2005","unstructured":"Nassiri-Kashani M, Firooz A, Khamesipour A, et al. A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis. J Eur Acad Dermatol Venereol. 2005;19:80\u20133.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"500_CR15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clindermatol.2006.05.008","volume":"25","author":"MS Bailey","year":"2007","unstructured":"Bailey MS, Lockwood DN. Cutaneous leishmaniasis. Clin Dermatol. 2007;25:203\u201311.","journal-title":"Clin Dermatol"},{"key":"500_CR16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-4632.2004.02002.x","volume":"43","author":"A Asilian","year":"2004","unstructured":"Asilian A, Sadeghinia A, Faghihi G, Momeni A. Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis. Int J Dermatol. 2004;43:281\u20133.","journal-title":"Int J Dermatol"},{"key":"500_CR17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-4362.1990.tb03759.x","volume":"29","author":"MA Eldarouti","year":"1990","unstructured":"Eldarouti MA, Alrubaie SM. Cutaneous leishmaniasis\u2014treatment with combined cryotherapy and intralesional stibogluconate injection. Int J Dermatol. 1990;29:56\u20139.","journal-title":"Int J Dermatol"},{"key":"500_CR18","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1365-4632.2006.02822.x","volume":"45","author":"R Salmanpour","year":"2006","unstructured":"Salmanpour R, Razmavar MR, Abtahi N. Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis. Int J Dermatol. 2006;45:1115\u20136.","journal-title":"Int J Dermatol"},{"key":"500_CR19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4269\/ajtmh.2011.10-0155","volume":"84","author":"A Chrusciak-Talhari","year":"2011","unstructured":"Chrusciak-Talhari A, Dietze R, Chrusciak TC, et al. Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania (Viannia) guyanensis in Manaus. Brazil. Am J Trop Med Hyg. 2011;84:255\u201360.","journal-title":"Brazil. Am J Trop Med Hyg"},{"key":"500_CR20","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","volume":"38","author":"J Soto","year":"2004","unstructured":"Soto J, Arana A, Toledo J, et al. Miltefosine for new world cutaneous leishmaniasis. Clin Infect Dis. 2004;38:1266\u201372.","journal-title":"Clin Infect Dis"},{"key":"500_CR21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4269\/ajtmh.2010.10-0060","volume":"83","author":"I Velez","year":"2010","unstructured":"Velez I, Lopez L, Sanchez X, Mestra L, Rojas C, Rodriguez E. Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis. Am J Trop Med Hyg. 2010;83:351\u20136.","journal-title":"Am J Trop Med Hyg"},{"key":"500_CR22","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/infdis\/jir816","volume":"205","author":"LC Rubiano","year":"2012","unstructured":"Rubiano LC, Miranda MC, Arenas SM, et al. Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children. J Infect Dis. 2012;205:684\u201392.","journal-title":"J Infect Dis"},{"key":"500_CR23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0002-9343(90)90292-L","volume":"89","author":"RE Saenz","year":"1990","unstructured":"Saenz RE, Paz H, Berman JD. Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis. Am J Med. 1990;89:147\u201355.","journal-title":"Am J Med"},{"key":"500_CR24","doi-asserted-by":"crossref","first-page":"e1688","DOI":"10.1371\/journal.pntd.0001688","volume":"6","author":"ES Wise","year":"2012","unstructured":"Wise ES, Armstrong MS, Watson J, Lockwood DN. Monitoring toxicity associated with parenteral sodium stibogluconate in the day-case management of returned travellers with new world cutaneous leishmaniasi. PLoS Negl Trop Dis. 2012;6:e1688.","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-013-0500-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-013-0500-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-013-0500-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T13:38:06Z","timestamp":1559482686000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-013-0500-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,9]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["500"],"URL":"https:\/\/doi.org\/10.1007\/s15010-013-0500-5","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,9]]}}}